Lifevantage director Garry Paul Mauro buys $11,848 in company stock

Published 05/09/2024, 12:18
Lifevantage director Garry Paul Mauro buys $11,848 in company stock

Garry Paul Mauro, a director at Lifevantage Corp (NASDAQ:LFVN), has purchased additional shares of the company, according to a recent filing with the Securities and Exchange Commission. On September 3, 2024, Mauro acquired a total of $11,848 worth of Lifevantage stock, priced at $7.405 per share.

The transaction involved the purchase of shares in various quantities, with the largest single buy amounting to 600 shares. This acquisition reflects a continued commitment by Mauro to the company, as indicated by the post-transaction share ownership figures. Following the purchase, Mauro directly owns 77,667 shares of Lifevantage Corp.

The report also reveals that Mauro made additional purchases through trusts associated with his family. The Francesco A. Mauro Trust of 2021, the Andrew H. Mauro Trust of 2021, the Dominic C. Mauro Trust of 2021, and the Garry Paul Mauro SEP IRA all saw increases in their holdings of Lifevantage stock on the same day.

These transactions demonstrate a strong vote of confidence from Mauro in the future of Lifevantage Corp, a company known for its work in the pharmaceutical preparations industry. The director's investment aligns with his role in guiding the company and showcases his belief in its potential value.

Investors often monitor insider buying as it can provide insights into the company's health and the sentiment of its executives and directors. Mauro's recent stock purchases may be seen as a positive sign by the market, as insiders usually buy shares when they believe the stock is undervalued or that there is potential for growth.

Lifevantage Corp has not made any official comments regarding these transactions. The details provided in this article are based solely on the SEC filing.

In other recent news, LifeVantage (NASDAQ:LFVN) Corporation has reported its financial results for the fourth quarter of the fiscal year 2024. Despite a nearly 10% decline in total revenues, the company has shown resilience by maintaining strong profitability, with an adjusted EBITDA margin of 9.8%, a 90 basis point improvement year-over-year. The company is combating this revenue dip with a focus on consultant engagement and the launch of new products, including a weight management system. LifeVantage also continues to prioritize shareholder value, as demonstrated by its share repurchase and dividend initiatives.

Projected revenue for fiscal 2025 is estimated to range from $200 million to $210 million, with adjusted non-GAAP EBITDA between $18 million and $21 million. Despite the challenging economic environment, the company maintains a strong financial position with $16.9 million in cash and no debt. In addition, LifeVantage has recently welcomed Raj Anbalagan to its Board of Directors, bringing his expertise in digital technologies to the table. These are among the recent developments for LifeVantage Corporation.

InvestingPro Insights

Lifevantage Corp (NASDAQ:LFVN) director Garry Paul Mauro's recent share purchase is a testament to his belief in the company's potential. This move aligns with other positive signals that investors may find noteworthy. InvestingPro Tips highlight that management has been aggressively buying back shares, which can often be interpreted as a sign of confidence in the company's future prospects. Additionally, Lifevantage holds more cash than debt on its balance sheet, providing financial stability and flexibility for future growth initiatives.

Looking at the recent InvestingPro Data, Lifevantage boasts an impressive gross profit margin of 79.3% for the last twelve months as of Q4 2024, indicating the company's ability to maintain profitability despite revenue challenges. The company's market capitalization stands at 109.57M USD, with a P/E ratio of 33.52, reflecting investor expectations for future earnings.

The company's stock has also experienced significant returns, with a 26.09% price total return over the last six months, and an even more remarkable year-to-date price total return of 47.84%. These metrics suggest a strong market performance and could be a contributing factor to the insider's decision to increase their stake in Lifevantage.

For investors seeking additional insights, there are numerous other InvestingPro Tips available, including information on net income growth expectations and the company's liquidity position. To explore these further, visit InvestingPro, where you can find a comprehensive list of tips to inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.